Preconception obesity is a strong predictor of glucose intolerance during pregnancy that has the potential to lead to adverse maternal and offspring effects. An increased prevalence of overweight offspring of obese mothers has been reported, despite normal values in an oral glucose tolerance test (OGTT) 1 during pregnancy (1 ) . Such findings might reflect effects of the intrauterine milieu, genetic background, or lifestyle factors related to maternal obesity or, alternatively, failure to diagnose glucose intolerance in obese pregnant women. We investigated whether increases in hemoglobin A 1c (Hb A 1c ) at delivery as a surrogate marker of glycometabolic disturbances are prevalent in obese mothers, despite the exclusion of gestational diabetes (GDM) even after applying the stringent new criteria as recommended by the International Association of Diabetes and Pregnancy Study Groups (IADPSG).
We performed a retrospective analysis of 137 obese pregnant Caucasian women. Recruitment was through an ongoing cohort study on the long-term effects of preconception maternal obesity (PEACHES, Programming of Enhanced Adiposity Risk in CHildhood -Early Screening), which had been initiated in 15 recruiting maternity clinics in Bavaria, Germany. Inclusion criteria before delivery were an age Ն18 years, singleton pregnancy, full-term birth, and a pregestation body mass index (BMI) Ն30 kg/m 2 . Women with a preexisting diagnosis of type 1 or type 2 diabetes mellitus or other chronic diseases were excluded. Ethics approval was obtained from the Ludwig-Maximilians-Universität München, and informed consent was provided by each participant.
The main exposure was the diagnosis or exclusion of GDM according to the results of a 75-g OGTT and the new IADPSG criteria or the former American Diabetes Association (ADA) criteria (Table 1). The primary outcome was an Hb A 1c value Ն5.7% at delivery, a threshold that has been reported to be above the reference interval for late pregnancy (2, 3 ) . Maternal EDTA-containing plasma samples were analyzed for Hb A 1c via cationexchange chromatography with a Tosoh G8 HPLC Analyzer (Tosoh Bioscience) in a central laboratory (interassay CV, Յ2.0%; analytical bias, Յ0.03% Hb A 1c at a target of 5.44%). A complete blood count was performed at delivery. Within subgroups, we compared the prevalence of increases in Hb A 1c by calculating the proportions with binomial 95% CIs (Table 1) and SAS software (version 9.2; SAS Institute).
According to the new IADPSG criteria, 38.9% (95% CI, 30.7%-47.5%) of the women had a GDM diagnosis, whereas the former ADA criteria yielded a percentage of only 8.0% (95% CI, 4.1%-13.9%). Subgroups did not differ significantly with respect to prepregnancy BMI, smoking during pregnancy, week of gestation of the OGTT, and parity. Iron deficiency anemia at delivery (4 ) was excluded by a complete blood count [mean corpuscular hemoglobin, 28.1 pg (median); mean corpuscular volume, 83.8 fL (median)].
The main finding was an increased prevalence of an increased Hb A 1c of Ն5.7% at delivery in obese women-even considering the lower limit of the 95% CIdespite the exclusion of GDM even by the sensitive new IADPSG criteria (Table 1 (4 ) . In addition to biological variation, the potential influence of analytical variation in Hb A 1c measurements on decision thresholds needs cautious interpretation. In our study, both analytical and preanalytical variation was low, and we included only Caucasian mothers and excluded relevant microcytic hypochromic anemia. Our finding that the prevalence of increased Hb A 1c values at delivery is still increased in seemingly nondiabetic obese preg-nancies may point toward the need for further refinement of GDM screening and/or the presence of glycometabolic disturbances beyond GDM in this high-risk group. Although requiring prospective assessment, Hb A 1c analysis at delivery might be beneficial. An apparently normal OGTT value would indicate to physicians an "all clear" situation without a need for special postnatal care, whereas in conjunction with an increased Hb A 1c value, it should raise awareness for the potentially hidden long-term risks of obese pregnancies. a Subgroups comprised women with excluded or confirmed GDM according to the former ADA criteria or the new IADPSG criteria. b The former ADA criteria could not be applied to 1 mother-child pair, because only a single blood glucose value was measured; Ն2 values must meet or exceed the criteria for a diagnosis of GDM [fasting, Ն95 mg/dL (Ն5.3 mmol/L); 1 h, Ն180 mg/dL (Ն10 mmol/L); 2h, Ն155 mg/dL (Ն8.6 mmol/L)]. This particular mother had an Hb A 1c value of 9.2% at delivery. c Any one of the following values must be met or exceeded: fasting, Ն92 mg/dL (Ն5.1 mmol/L); 1 h, Ն180 mg/dL (Ն10 mmol/L); 2 h, Ն153 mg/dL (Ն8.5 mmol/L). d LGA, large for gestational age (defined as birth weight Ն90th percentile).
